|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.404 EUR | +10.41% |
|
+14.50% | -14.29% |
| 06-15 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
| 04-27 | Clinuvel Pharmaceuticals plans level II ADR upgrade and Nasdaq listing as CUVL | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.33% | -0.25% | -3.13% | -18.03% | -20.98% | +18.76% | -22.11% | +13.39% | +72.20% | 62.05B | |
| 0.00% | -9.35% | +6.09% | -1.11% | +4.44% | +58.07% | +195.96% | +192.42% | +285.58% | 54.45B | |
| +4.38% | +43.00% | +43.00% | +43.00% | +43.00% | +43.00% | +43.00% | +43.00% | - | 43.09B | |
| +7.62% | +8.19% | +17.86% | -13.59% | -32.63% | -51.27% | -59.11% | -61.86% | +7.61% | 36.37B | |
| -1.05% | -1.69% | +2.43% | +7.83% | +11.70% | +55.35% | -33.92% | -49.39% | -17.48% | 29.02B | |
| +3.50% | +28.85% | +32.95% | +22.06% | +116.89% | +151.81% | -50.31% | -67.89% | - | 25.38B | |
| -0.78% | -8.91% | +3.18% | +6.48% | -0.56% | +43.87% | +55.34% | +16.98% | +27.38% | 19.62B | |
| +1.74% | +4.39% | -5.17% | -10.25% | -0.13% | -3.12% | +107.49% | -12.02% | - | 16.89B | |
| -0.05% | +0.41% | +1.38% | +17.76% | +32.27% | +56.32% | +94.95% | +188.56% | +334.55% | 15.93B | |
| -1.66% | -1.89% | +1.45% | -5.49% | -13.36% | +65.68% | +341.51% | +8.05% | - | 12.98B | |
| -0.66% | -1.29% | +10.16% | +58.67% | +37.16% | +143.46% | +194.71% | +271.94% | +3,851.10% | 12.89B | |
| -0.94% | +6.48% | +3.36% | +4.08% | -17.80% | -6.46% | +747.48% | +464.12% | +6,412.61% | 12.88B | |
| -0.60% | -1.53% | +10.11% | -1.34% | -7.98% | -1.00% | -43.20% | -33.22% | -34.78% | 10.57B | |
| +1.87% | +8.25% | +19.30% | +38.76% | +41.18% | +163.50% | +186.61% | +433.02% | - | 10.26B | |
| +0.72% | +0.80% | -0.39% | +2.36% | -14.90% | -9.80% | -22.17% | -60.60% | -51.87% | 6.27B | |
| +5.66% | +18.24% | +75.86% | +96.94% | +176.04% | +143.97% | +378.21% | -21.29% | - | 5.45B | |
| -0.24% | -1.35% | -28.51% | -30.22% | -36.49% | -54.63% | -57.75% | -77.10% | - | 5.34B | |
| +3.53% | +5.97% | -10.07% | -12.74% | -2.27% | +4.31% | +246.12% | +179.22% | - | 5.32B | |
| +1.06% | -0.06% | -16.38% | -30.76% | -32.88% | -24.34% | +118.15% | +47.55% | +118.73% | 5.18B | |
| Average | +1.29% | +3.20% | +8.60% | +9.18% | +14.88% | +41.97% | +127.42% | +77.63% | +1,000.51% | 20.52B | |
| Weighted average by Cap. | +1.51% | +2.37% | +10.67% | +6.36% | +11.07% | +41.27% | +83.91% | +63.76% | +595.07% |
- Stock Market
- Stocks
- CUV Stock
- UR9 Stock
- Sector Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
